The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers-Reference-Cited by-同舟云学术

The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers

Published:2011-09 Issue:9 Volume:21 Page:523-530
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Yamada Akihiro,Maeda Kazuya,Ishiguro Naoki,Tsuda Yasuhiro,Igarashi Takashi,Ebner Thomas,Roth Willy,Ikushiro Shinichi,Sugiyama Yuichi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference31 articles.

1. A review on telmisartran: a novel, long-acting angiotensin II receptor antagonist.;Wienen;Cardiovasc Drug Rev,2000

2. Pharmacokinetics and safety of intravenous and oral telmisartan 20 and 120 mg in subjects with hepatic impairment compared with healthy volunteers.;Stangier;J Clin Pharmacol,2000

3. Absorption, metabolism, and excretion of intravenously and orally administered 14Ctelmisartan in healthy volunteers.;Stangier;J Clin Pharmacol,2000

4. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1.;Abe;J Biol Chem,1999

5. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters.;Hsiang;J Biol Chem,1999

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target‐mediated drug disposition and OATP1B3‐mediated hepatic uptake in a physiologically based model;CPT: Pharmacometrics & Systems Pharmacology;2024-05-14

2. The therapeutic landscape for COVID-19 and post-COVID-19 medications from genetic profiling of the Vietnamese population and a predictive model of drug-drug interaction for comorbid COVID-19 patients;Heliyon;2024-03

3. Effects of telmisartan on metabolic syndrome components: a comprehensive review;Biomedicine & Pharmacotherapy;2024-02

4. Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation;Pharmacology & Therapeutics;2022-10

5. Selection of the candidate compound at an early stage of new drug development: retrospective pharmacokinetic and metabolic evaluations of valsartan using common marmosets;Xenobiotica;2022-06-03